Alicia Burr, APRN
Family · New Haven, CTNPI 1225028665
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (29.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 96.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $10,462 and has fallen 95.0% since, to $525 in 2025. Among family clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $218.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- AbbVie$385
- Biotronik Inc.$149
- Boston Scientific$83
What the payments were for
- Consulting fees$3,74123%
- Speaking & faculty fees$4,90029%
- Travel & lodging$4,57228%
- Food & beverage$3,22719%
- Education$1811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 63 | $16,002 |
| AbbVie(2 entities) | 6 | $385 |
| Biotronik Inc. | 5 | $149 |
| Boston Scientific | 2 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reveal LINQ$2,100
- LINQ II$1,055
- Micra$522
- BOTOX$106
How this compares
$16,620 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 117 | $83,997 |
| Dofetilide | 24 | $3,706 |
| Amiodarone Hcl | 73 | $1,647 |
| Metoprolol Succinate | 68 | $1,145 |
| SotalolSotalol Hcl | 49 | $1,069 |
| Colchicine | 27 | $285 |
| Pantoprazole Sodium | 42 | $272 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $191 |
| Flecainide Acetate | 15 | $143 |
| Metoprolol Tartrate | 16 | $89 |
| ClopidogrelClopidogrel Bisulfate | 11 | $58 |
| Lisinopril | 12 | $50 |
| Furosemide | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Other family in New Haven
- Dayna GiordanoNew Haven$65K
- Michael TawiahNew Haven$10K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.